期刊文献+

促红细胞生成素联合不同剂量维生素E在防治早产儿贫血中的临床研究 被引量:6

Therapeutic effects of erythropoietin and different doses of vitamin E on the prevention of anemia in pre- mature children
原文传递
导出
摘要 目的探讨维生素E(VitE)在防治早产儿贫血中的临床疗效。方法选择我院新生儿病房2010年12月至2011年12月收治的早产儿90例,按入住先后顺序随机分为对照组(A组)、VitE大剂量组(B组)、VitE小剂量组(C组)。A组30例,入院后第7天起给予促红细胞生成素(EPO),每周750IU/kg分3次皮下注射,共4周;同时加服铁剂每日6mg/kg。另2组在上述对照治疗的基础上,加服不同剂量VitE,共4周。B组30例,VitE每日15mg/kg;c组30例,VitE每Et2.5mg/kg。观察治疗过程中各组血细胞压积(Hct)、血红蛋白(Hb)、红细胞(RBC)、网织红细胞(Ret)及其治疗前后血清VitE浓度的变化。结果治疗后B、C组患者Hct、Hb、RBC、Ret均有所改善,各项指标改善程度与A组比较,差异有统计学意义(P〈0.05),B与C组各项指标改善程度未见明显差异(P〉0.05)。B、C组治疗后血清VitE浓度可见明显升高,且差异有统计学意义(P〈0.05),A组患者上升不明显。结论在EPO防治早产儿贫血的同时应加腽小剂量VitE. Objective To research the therapeutic effect of vitamin E in prevention and treatment of anemia in premature children. Methods We investigated 90 cases of premature children admitted to the neonatal ward of our hospital from December 2010 to December 2011. According to hospital successively order these premature were randomly divided into control group (Group A ), high-dose group (Group B ), low-dose group ( Group A). Group A including 30 cases, subcutaneous injection of erythropoietin (EPO) from the 7th days after admission ,750IU/kg weekly for 3 times ,for 4 weeks. At the same time,plus iron 6mg/(kg·d). On the basis of the above-mentioned control treatment, oral administration of different doses of vitamin E was in the treatment group ,for 4 weeks. Group B including 30 cases was given vitamin E 15mg/(kg·d). Group C including 30 cases was given vitamin E 2. 5 rag/( kg· d). The changes of each group during the treatment in hematocrit (Hct), hemoglobin ( Hb ), red blood cell ( RBC), reticulocyte (Ret) and the changes of serum concentrations of vitamin E before and after treatment were observed. Results Hct, Hb, RBC, Ret in group B, group C patients were both improved. The improvement of the indicators was better than that of group A ( P 〈 0. 05 ). There was no significant difference between the improvement of each index of Group B and Group C( P 〉 0. 05 ). Serum concentrations of vitamin E after treatment in group B and group C patients were significantly higher and the difference was statistically significant( P 〈0. 05). Serum concentration of vitamin E in group A didn't increase obviously. Conclusion Additional small doses of VitE should be given during EPO prevention of anemia in premature children.
出处 《国际儿科学杂志》 2013年第2期204-207,共4页 International Journal of Pediatrics
关键词 促红细胞生成素 维生素E 早产儿贫血 Erythropoietin Vitamin E Anemia of prematurity
  • 相关文献

参考文献17

  • 1张秀琴,严文康,何映星,周春梅,张伟忠.不同剂量促红细胞生成素防治早产儿贫血临床观察[J].中国小儿急救医学,2006,13(2):156-157. 被引量:8
  • 2Strauss RG, Anaemia of Prematurity: Pathophysiology & Treatment. Blood Rev,2010,24(6) :221-225.
  • 3Von Kohom I, Ehrenkranz RA. Anemia in the preterm infant:eryth- ropoietin versus erythrocyte transfusion -- It's not that simple. Clin Perinato1,2009,36 ( 1 ) : 111-123.
  • 4夏桂枝,张国成.促红细胞生成素与缺氧缺血性脑损伤[J].国际儿科学杂志,2006,33(1):48-51. 被引量:8
  • 5Khatami SF,Mamouri G,Torkaman M. Effects of early human re- combinant erythropoietin therapy on the transfusion in healthy pre- term infants. Indian J Pediatr,2008,75 ( 12 ) : 1227-1230.
  • 6常立文,刘皖君,廖财绪,赵锡慈.不同剂量重组人类促红细胞生成素防治早产儿贫血的疗效观察[J].中国实用儿科杂志,2000,15(12):740-742. 被引量:36
  • 7Rocha VL, Benjamin AC, Procianoy RS. The effect of recombinant human erythropoietin on the treatment of anemia of prematurity. J Pediatr(Rio J) ,2001,77(2) :75-83.
  • 8Hass C, Genzel-Boroviczeny O, Koletzko B. Losses of vitamin A and E in parenteral nureition suitable for premature infants. Eur J Clin Nutr,2002,56 (9) :906-912.
  • 9Pathak A, Roth P, Piscitelli J, et al. Effects of vitamin E supplemen- tation during erythropoietin treatment of the anaemia of prematurity. Arch Dis Child Fetal Neonatal Ed,2003,88(4) :F324-F328.
  • 10邵肖梅,叶鸿瑁,丘小汕.实用新生儿学.4版.北京:人民卫生出版社,201l:46,954-959.

二级参考文献39

  • 1Digicaylioglu M,Lipton SA.Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-κB singnaling cascades[J].Nature,2001,412(6847):641-647.
  • 2Wen TC,Sadamoto Y,Tanaka J,et al.Erythropoietin protects neurons against chemical hypoxia and cerebral ischemia injury by up-regulating Bcl-xL expression[J].J Neurosci Res,2002,67(6):795-803.
  • 3Heeschen C,Aicher A,Lebmann R,et al.Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization[J].Blood,2003,102(4):1340-1346.
  • 4Chong ZZ,Kang JQ,Maiese K.Erythropoietin is a novel vascular protectant through activation of Akt1 and mitochondrial modulation of cysteine proteases[J].Circulation,2002,106(23):2973-2979.
  • 5Juul SE,McPherson RJ,Farrell FX,et al.Erythrpoietin concentration in cerebrospinal fluid of nonhuman primates and fetal sheep following high-dose recombinant erythropoietin[J].Biol Neonate,2004,85(2):138-144.
  • 6Erbayraktar S,Grasso G,Sfacteria A,et al.Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotcetive activity in vivo[J].Proc Natl Acad Sci USA,2003,100(11):6741-6746.
  • 7Prass K,Ruscher K,Karsch M,et al.Desferrioxamine induces delayed tolerance against cerebral ischemia in vivo and in vitro[J].J Cereb Blood Flow Metab,2002,22(5):520-525.
  • 8Wang CH,Liang CL,Huang LT,et al.Single intravenous injection of naked plasmid DNA encoding erythropoietin provides neuroprotection in hypoxia-ischemia rats[J].Biochem Biophys Res Commun,2004,314(4):1064-1071.
  • 9Ehrenreich H,Hasselblatt M,Dembowski C,et al.Erythropoietin therapy for acute stroke is both safe and beneficial[J].Mol Med,2002,8(8):495-505.
  • 10Juul S.Erythropoietin in the central nervous system and its use to prevent hypoxic-ischemic brain damage[J].Acta Paediatr Suupl,2002,91(438):36-42.

共引文献110

同被引文献48

引证文献6

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部